Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

10.13
Delayed Data
As of 10:43am ET
 +0.19 / +1.91%
Today’s Change
5.38
Today|||52-Week Range
10.83
+32.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$224.2M

Company Description

Enzymotec Ltd. engages in supplying of specialty lipid-based products and solutions. It develop, manufacture and market innovative bio-functional lipid ingredients, as well as final products, based on sophisticated proprietary processes and technologies. It operates through Nutrition and VAYA Pharma segments. The Nutrition segment develops, and manufactures nutritional ingredients for infant formulas and dietary supplements. The VAYA Pharma segment develops, manufactures, and sells branded lipid-based medical foods for the dietary management of medical disorders and common diseases. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel.

Contact Information

Enzymotec Ltd.
Sagi 2000 Industrial Park
Migdal HaEmeq Hazafon 23106
P:972747177177
Investor Relations:

Employees

Shareholders

Other institutional35.17%
Mutual fund holders3.89%
Individual stakeholders--

Top Executives

Ariel KatzPresident & Chief Executive Officer
Yariv GratzVice President-Operations
Oren BryanChief Financial Officer & Vice President
Ariel BlumovichVice President-Business Development
Shachar CarmiVice President-Sales